Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 439

Similar articles for PubMed (Select 15003147)

1.

A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.

Oosthuizen P, Emsley R, Jadri Turner H, Keyter N.

Int J Neuropsychopharmacol. 2004 Jun;7(2):125-31. Epub 2004 Mar 5.

PMID:
15003147
2.

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.

Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9.

PMID:
18466670
3.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
4.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G; Early Psychosis Global Working Group.

Am J Psychiatry. 2005 May;162(5):947-53.

PMID:
15863797
5.

Determining the optimal dose of haloperidol in first-episode psychosis.

Oosthuizen P, Emsley RA, Turner J, Keyter N.

J Psychopharmacol. 2001 Dec;15(4):251-5.

PMID:
11769818
6.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
7.

Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.

Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.

J Clin Psychiatry. 2003 Sep;64(9):1075-80.

PMID:
14628983
8.

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.

Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA.

Am J Psychiatry. 2004 Jun;161(6):985-95.

PMID:
15169686
9.

A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.

Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L, et al.

Acta Psychiatr Scand Suppl. 1990;358:130-5.

PMID:
1978472
10.

The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.

Garcia E, Robert M, Peris F, Nakamura H, Sato N, Terazawa Y.

CNS Drugs. 2009;23(7):615-25. doi: 10.2165/00023210-200923070-00006.

PMID:
19552488
11.

Optimal haloperidol dosage in first-episode psychosis.

Zhang-Wong J, Zipursky RB, Beiser M, Bean G.

Can J Psychiatry. 1999 Mar;44(2):164-7.

PMID:
10097837
12.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
13.
14.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
15.

A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.

Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.

Acta Psychiatr Scand Suppl. 1990;358:125-9.

PMID:
1978471
16.

Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.

Apiquian R, Fresán A, Herrera K, Ulloa RE, Lóyzaga C, de la Fuente-Sandoval C, Gutiérrez D, Nicolini H.

Int J Neuropsychopharmacol. 2003 Dec;6(4):403-8.

PMID:
14604455
17.

Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.

Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I, Sanger T, Kapur S.

Can J Psychiatry. 2005 Jul;50(8):462-9.

PMID:
16127964
18.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
20.

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

Emsley R, Rabinowitz J, Medori R; Early Psychosis Global Working Group.

Schizophr Res. 2007 Jan;89(1-3):129-39. Epub 2006 Nov 7.

PMID:
17095194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk